openPR Logo
Press release

Post-operative Pain Management Market Shows Highest Growth Potential of 5.4% by 2023

10-02-2017 10:03 PM CET | Health & Medicine

Press release from: Market Research Future

Post-operative Pain Management Market Shows Highest Growth

Market Research Future adds new report of “Post-operative Pain Management Market - Global forecast to 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

• Teva Pharmaceutical Industries Ltd. (Israel)
• Eli Lilly (U.S)
• Pfizer (U.S)
• Johnson & Johnson (U.S)
• Purdue Pharma (U.S)
• Endo Pharmaceuticals Plc. (U.S)
• Forest Laboratories Inc. (U.S)
• GlaxoSmithKline Plc. (UK)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Baxter International Inc. (US)
• Valeant Pharmaceuticals International Inc. (Canada)

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1246

Market Segmentation:

Global post-operative pain management market is segmented on the basis of pain type into acute pain, moderate pain and severe pain.

• On the basis of Product they are segmented into non-steroidal anti-inflammatory drugs (NSAIDs), antiepileptic drugs, COX-2 inhibitors, opioids

• On the basis of Application they are segmented into cancer pain, arthritic pain, neuropathic pain, musculoskeletal pain, migraine

• On the basis of Target Area they are back, legs, hand and arms

Market Highlight:

Post-operative pain management is a branch of the that deals with the minimizing the pain occur due to tissue injury together with muscle spasm to the patients after surgery. It is the branch of pain management. Global post- operative pain management market is growing steadily due to increasing demand for the pain control drugs and devices. Increasing number of surgeries across the globe and increasing prevalence of different diseases across the globe is the major factor for the growth of the market. Increasing age rises the possibility of the different complication, this increasing aging population is also has a synergistic impact of the growth of the market. According to the Centre for Disease Control and Prevention during last decade due to overdose of the analgesic drugs number of deaths has increased. Analgesic drugs are habit forming drugs and thus side effects of the treatment and habit forming nature of the drugs can hamper the growth of the market.

Global Post-operative pain management market was expected to grow at a CAGR of 5.4% during forecasted period 2017-2023.

Browse Report Details @ https://www.marketresearchfuture.com/reports/post-operative-pain-management-market

Study objectives global post-operative pain management market

• Detail analysis of global post-operative pain management market with region specific growth and competitive analysis on the basis of major players present in the market

• Detail analysis of global post-operative pain management market and different drivers and restraints affecting the growth of the market

• Detailed analysis of the historical and forecasted market Analysis of the market on the basis of factors like- price analysis, supply chain analysis, porters five force analysis etc.

• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global anesthesia delivery devices market.

Intended Audience

• Pharmaceutical companies
• Medical devices manufacturer and suppliers
• Research and Development (R&D) Companies
• Government Research Laboratories
• Independent Research Laboratories
• Government and Independent Regulatory Authorities
• Market Research and Consulting Service Providers
• Medical Research Laboratories
• Academic Medical Institutes and Universities

Enquire about this Report @ https://www.marketresearchfuture.com/enquiry-before-buy/1246

Regional analysis

Geographically, America accounts the largest share for global post-operative pain management market. Increasing number of surgeries and rising burden of chronic diseases has led to the growth of this market in America. Europe commands second largest market which is followed by Asia Pacific. Asia Pacific is the fastest growing region for the market due to increasing prevalence of many diseases, increasing aging population and development in healthcare infrastructure in this region has provided fuel for the growth of the market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Post-operative Pain Management Market Shows Highest Growth Potential of 5.4% by 2023 here

News-ID: 750647 • Views:

More Releases from Market Research Future

Global Neuroendoscopy Market to Surpass USD 1297.9 Billion by 2035 as AI-Guided Navigation and Minimally Invasive Techniques Redefine Neurosurgery
Global Neuroendoscopy Market to Surpass USD 1297.9 Billion by 2035 as AI-Guided …
The global Neuroendoscopy Market is entering a high-growth phase, fueled by a surge in brain tumor cases and the rapid integration of robotics and artificial intelligence into surgical workflows. According to the latest 2026 industry intelligence, the market is valued at approximately USD 444.04 million and is projected to reach USD 1,297.90 million by 2035, expanding at a robust compound annual growth rate (CAGR) of 11.39%. Neuroendoscopy has emerged as a
Global Stem Cell Assay Market Set to Reach USD 10.27 Billion by 2035 as Regenerative Medicine and Drug Discovery Enter New Era
Global Stem Cell Assay Market Set to Reach USD 10.27 Billion by 2035 as Regenera …
The global Stem Cell Assay Market is experiencing a period of exponential growth, fueled by the rapid expansion of regenerative medicine and a surging demand for physiologically relevant models in drug toxicity testing. According to recent industry analysis for 2026, the market is valued at approximately USD 5.04 billion and is projected to reach USD 10.27 billion by 2035, exhibiting a robust compound annual growth rate (CAGR) of 8.22%. As pharmaceutical
Global Healthcare IT Market Projected to Surpass USD 1,650.34 billion by 2035, Catalyzed by Generative AI and Cloud-Native Ecosystems
Global Healthcare IT Market Projected to Surpass USD 1,650.34 billion by 2035, C …
The global Healthcare IT Market is entering a new era of hyper-growth, driven by the mass adoption of generative AI, the decentralization of patient care, and a critical industry-wide push for data interoperability. According to the latest market intelligence, the sector is valued at approximately USD 386.58 billion in 2026 and is forecasted to accelerate at a remarkable compound annual growth rate (CAGR) of 17.5%, reaching USD 1,650.34 billion by
Global Medical Foods Market Poised to Reach USD 40.77 Billion by 2035, Driven by Personalized Nutrition and Chronic Disease Management
Global Medical Foods Market Poised to Reach USD 40.77 Billion by 2035, Driven by …
The global Medical Foods Market is undergoing a significant transformation, fueled by a paradigm shift in healthcare toward specialized, condition-specific nutritional interventions. According to the latest industry analysis, the market was valued at approximately USD 24.04 billion in 2024 and is projected to expand at a steady compound annual growth rate (CAGR) of 4.92%, reaching a staggering USD 40.77 billion by 2035. Medical foods, which are specifically formulated for the dietary

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the